Company / Return on Assets (ROA)
LIPELLA PHARMACEUTICALS INC. Return on Assets (ROA) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-187.6%
FY2024
5-year range
-187.6% / -43.7%
FY2022-FY2024
Trend
-45.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -43.7% to -187.6% over the past 2 years.
Based on SEC 10-K filings.
-187.6% in FY2024.
Declined from -43.7% to -187.6% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on assets (roa) decreased 45.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -187.6% | -45.3% |
| FY2023 | -129.1% | -195.7% |
| FY2022 | -43.7% | - |
As of FY2024 · SEC Form 10-K · Last checked Jun 29, 2026